Redsense Medical AB

Financial Reports

This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.

2024

Interim report Q2 2024
Interim report Q1 2024

2023

Årsredovisning 2023
Annual Report 2023 *This is an English translation of Årsredovisning 2023

Year-end report 2023

Interim report Q3 2023
Interim report Q2 2023
Interim report Q1 2023

2022

Årsredovisning 2022
Annual Report 2022 *This is an English translation of Årsredovisning 2022

Year-end report 2022

Interim report Q3 2022
Interim report Q2 2022
Interim report Q1 2022

2021

Årsredovisning 2021
Annual report 2021 *This is an English translation of Årsredovisning 2021

Year-end report 2021

Interim report Q3 2021
Interim report Q2 2021
Interim report Q1 2021

2020

Årsredovisning 2020
Annual report 2020 *This is an English translation of Årsredovisning 2020

Year-end report 2020

Interim report Q3 2020
Interim report Q2 2020
Interim report Q1 2020

2019

Årsredovisning 2019
Annual report 2019 *This is an English translation of Årsredovisning 2019

Year-end report 2019

Interim report Q3 2019
Interim report Q2 2019
Interim report Q1 2019

2018

Årsredovisning 2018

Year-end report 2018

Interim report Q3 2018
Interim report Q2 2018
Interim report Q1 2018

2017

Årsredovisning 2017

Year-end report 2017

Interim report Q3 2017
Interim report Q2 2017

2016

Årsredovisning 2016

Year-end report 2016

Interim report Q3 2016
Interim report Q2 2016
Interim report Q1 2016